What Cureety does

Cureety SAS is a French digital health company, headquartered in Dinan, France, that builds an oncology-specialized remote patient monitoring and care coordination platform. The platform converts patient-reported symptoms into CTCAE v6.0-graded clinical intelligence layered against the patient's specific treatment regimen, cancer type, and history, enabling cancer centers and hospitals to triage critical signals earlier and with less alert fatigue. Its two core modules — Precision Patient Monitoring and Precision Care Management — are supported by a free patient and caregiver app (iOS, Android, web) and a Scientific Committee drawing oncologists from institutions including Gustave Roussy, MD Anderson, Moffitt, Yale, and City of Hope.

The company's technology backbone is a therapy-specific triage algorithm validated with 95.8% sensitivity and 94.4% specificity over 400+ patients (ASCO 2023) and benchmarked to generate roughly 60% fewer red alerts than PRO-CTCAE-based systems across 2.46 million adverse events (Argos II 2026). Care Management extends the platform into automated treatment calendars, infusion readiness checks that integrate labs and patient-reported toxicity, adherence monitoring, and automated billing documentation for U.S. Remote Therapeutic Monitoring (RTM), Chronic Care Management (CCM), and Principal Illness Navigation (PIN) codes. The platform syncs with existing EHR infrastructure and holds HIPAA, ISO 13485, and ISO 27001 certifications.

Cureety sells primarily on a subscription basis to hospitals, cancer centers, and oncology departments via direct enterprise sales, supported by scientific-committee endorsements and partnerships with AVBCC, ACCC, NCODA, and Judi. Customers cited include AP-HP, CHU de Lyon, CHU de Montpellier, CHU Saint-Etienne, CHU Reims, CHRU Tours, Institut Godinot, Centre François Baclesse, CH Dunkerque, and Portuguese operator Hospital Cálice (Lusiadas Saude). Pricing is quote-based and not publicly disclosed; the patient app is free and distributed only via healthcare-provider prescription. As of the January 2022 funding round (€5M led by French mutual insurers with Bpifrance), the company had supported over 70,000 patients and 3,500+ healthcare professionals across 250+ cancer centers globally and was planning an office in Italy as part of European expansion.

Name

Cureety

Legal name

Cureety SAS

Website

https://cureety.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Cureety SAS is a French digital health company that provides an oncology-specialized remote patient monitoring and care coordination platform to hospitals and cancer centers, using a therapy-specific triage algorithm that converts patient-reported symptoms into CTCAE-graded clinical intelligence to detect toxicity earlier and reduce hospitalizations.

Ownership category

akta.pro rank

Headquarters

HQ city

Dinan

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Healthcare Institution Subscriptions: Cureety provides its remote monitoring platform to healthcare institutions including cancer centers and hospitals on a subscription basis. The platform enables remote therapeutic monitoring (RTM), chronic care management (CCM), and principal illness navigation (PIN) billing.
2. Patient App (Free for Patients): The Cureety patient app is provided free of charge to patients, prescribed by healthcare providers. Revenue is generated through healthcare institution subscriptions, not direct patient billing.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Cureety provides an oncology-specialized remote monitoring platform that transforms patient-reported symptoms into CTCAE-graded, therapy-specific clinical intelligence for cancer care teams. The platform comprises Precision Patient Monitoring and Precision Care Management modules, plus a free Cureety App for patients and caregivers, enabling proactive intervention, treatment readiness checks, and care coordination between clinic visits.

Product overview

Cureety offers a unified oncology precision care platform comprising two core modules — Precision patient monitoring and Precision care Management — plus a patient-facing Cureety App. The platform is built on therapy-specific algorithms that map patient-reported symptoms directly to CTCAE grades, enabling intelligent triage that differentiates critical signals from routine side effects based on the patient's specific treatment regimen, cancer type, and clinical history. Precision patient monitoring handles remote symptom monitoring and early risk detection, while Precision care Management orchestrates treatment calendars, infusion readiness checks, adherence monitoring, and billing documentation. Both modules share a unified intelligence layer and connect to EHR systems via built-in sync.

Differentiator

Problem solved

Functional benefit

Products and services

• Precision Patient Monitoring Oncology-specialized remote monitoring module that transforms patient-reported symptoms into CTCAE-graded, therapy-specific triage intelligence. Uses validated algorithms to detect critical signals early and reduce alert fatigue by 60% versus PRO-CTCAE based systems. Designed for oncology care teams at cancer centers and hospitals.
• Precision Care Management Care coordination and workflow management module that automates treatment calendars, treatment readiness checks integrating lab results with patient toxicity reports, treatment adherence monitoring, and billing documentation (RTM, CCM, PIN). Connects the entire oncology care team in one orchestrated system. Designed for clinicians and care teams at cancer centers.
• Cureety App Free patient and caregiver mobile and web application for daily symptom reporting, treatment guidance, appointment reminders, and secure communication with care teams. Prescribed by healthcare providers and provided free of charge to oncology patients.

Quantifiable outcome

• 61% reduction in hospitalization stays through proactive toxicity detection
• +8 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature8 records

Partnerships

Four partnerships are on record, tiered supporting.

• JudisupportingStrategic or Co-development PartnerListed as Expert Partner in Cureety's strategic partner network. Judi provides expertise in oncology digital health solutions.
• AVBCC (Advanced Vaginal & Bladder Cancer Consortium - Association of Value-Based Cancer Care)supportingStrategic or Co-development PartnerListed as Scientific Association partner. AVBCC is a scientific association focused on value-based cancer care, aligning with Cureety's mission.
• ACCC (Association of Community Cancer Centers)supportingStrategic or Co-development PartnerListed as strategic partner. ACCC represents community cancer centers, providing a network for Cureety's oncology monitoring platform.
• NCODAsupportingStrategic or Co-development PartnerListed as strategic partner. NCODA is an organization supporting oral chemotherapy and oncology care, aligning with Cureety's treatment adherence monitoring capabilities.

Scale indicators14 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Medocity: Remote patient monitoring and virtual care platform with oncology as one of its target conditions. Smaller and more generalist than Cureety but addresses similar use cases of symptom tracking, care coordination, and EHR integration for cancer patients.
• Thyme Care: US oncology navigation and care management company that combines human navigators with technology to support cancer patients. Adjacent to Cureety's oncology care management capabilities but with stronger emphasis on human-led navigation and US payer/provider contracting.

Broad incumbents

• Vivify Health: Established remote patient monitoring platform supporting multiple chronic conditions including oncology-adjacent use cases. Broader and therapy-agnostic compared with Cureety, but competes for the same RPM budgets in large health systems.
• Flatiron Health: Oncology-specific electronic health record and real-world evidence platform owned by Roche. Operates broadly in oncology technology with deep US cancer center penetration, and overlaps with Cureety's RWE and clinical decision-support ambitions, though it does not focus on patient-facing symptom monitoring.
• Tempus Labs: Large US oncology AI and data company offering molecular profiling, clinical decision support, and real-world evidence. Competes with Cureety in oncology clinical intelligence and pharma RWE, with substantially greater capital and data scale.

Direct peers

• Kaiku Health: Direct competitor in oncology-specific patient-reported outcomes and remote symptom monitoring. Originally Finnish, acquired by Elekta in 2021, Kaiku Health serves cancer centers across Europe and globally with a similar therapy-specific monitoring approach, making it Cureety's closest head-to-head competitor.
• Noona Healthcare: Oncology patient engagement and symptom management platform originally from Finland, acquired by Varian (now Siemens Healthineers). Targets the same cancer-center customer with PRO-based remote monitoring and is embedded in radiation oncology workflows — a direct overlap with Cureety's oncology RPM offering.
• Force Therapeutics: Digital care management platform originally focused on musculoskeletal conditions but expanding into oncology and other specialties with patient-facing remote monitoring and care pathways. Comparable enterprise sales motion and remote monitoring architecture.
• Carevive Systems: US-based oncology remote patient monitoring and care management platform serving cancer centers with symptom tracking, care plans, and patient engagement. Competes for the same institutional oncology customers as Cureety, particularly in the US value-based care market.
• Navigating Cancer: US oncology patient platform providing symptom monitoring, care plans, and patient engagement for cancer centers and oncology practices. Directly comparable product offering and customer base to Cureety in the oncology RPM category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cureety